Evidence map›Paper›PMID 27918637›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2017

Intermolecular Aryl C-H Amination through Sequential Iron and Copper Catalysis.

Mohamed A B Mostafa, Ewen D D Calder, Daugirdas T Racys, Andrew Sutherland

Open access · hybridAbstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Triflamides and Triflimides: Synthesis and Applications.Molecules (Basel, Switzerland) · 2022
    Review
  6. Recent Progress Concerning theMolecules (Basel, Switzerland) · 2021
    Review
  7. Synthesis of Benzo[Organic letters · 2020
    Article
  8. Intermolecular Aryl C-H Amination through Sequential Iron and Copper Catalysis.Chemistry (Weinheim an der Bergstrasse, Germany) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mohamed A B MostafaWestCHEM, School of Chemistry, The Joseph Black Building, University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK.
Ewen D D CalderWestCHEM, School of Chemistry, The Joseph Black Building, University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK.
Daugirdas T RacysWestCHEM, School of Chemistry, The Joseph Black Building, University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK.
Andrew SutherlandWestCHEM, School of Chemistry, The Joseph Black Building, University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK.ORCID http://orcid.org/0000-0001-7907-5766
University of Glasgow · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A mild, efficient and regioselective method for para-amination of activated arenes has been developed through a combination of iron and copper catalysis. A diverse range of products were obtained from an operationally simple one-pot, two-step procedure involving bromination of the aryl substrate with the powerful Lewis acid iron(III) triflimide, followed by a copper(I)-catalysed N-arylation reaction. This two-step dehydrogenative process for the regioselective coupling of aromatic C-H bonds with non-activated amines was applicable to anisole-, phenol-, aniline- and acetanilide-type aryl compounds. Importantly, the arene substrates were used as the limiting reagent and required no protecting-group manipulations during the transformation.

Indexed as

aminationbrominationcopper catalysiscross-couplingiron catalysis

Identifiers

PMID27918637
PMCPMC5396366
OpenAlexW2560476770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.